Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer

Zunyi Medical College1 site in 1 country364 target enrollmentAugust 1, 2022

ConditionsColorectal Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Colorectal Cancer
Sponsor: Zunyi Medical College
Enrollment: 364
Locations: 1
Primary Endpoint: Status of frailty
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Fried Scale and its related scales were used to analyze the status and risk factors of preoperative frailty in elderly patients with colorectal cancer. R software was used to construct a risk prediction model for preoperative frailty in elderly patients with colorectal cancer, and its validity and stability were verified in clinical practice.

Registry

clinicaltrials.gov

Start Date

August 1, 2022

End Date

July 31, 2025

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Zunyi Medical College

Responsible Party

Principal Investigator

Yongmei Zhang

Study Director

Zunyi Medical College

Eligibility Criteria

Inclusion Criteria

•patients who met the diagnostic criteria of colorectal cancer in Chinese Guidelines for Diagnosis and Treatment of Colorectal Cancer 2020 Edition and underwent surgery;
•patients aged ≥60 years old ;
•patients who are clearly conscious, able to understand instructions, communicate normally, and complete the physical activity ability test without the assistance of others;
•patients who gave informed consent and volunteered to participate in the study.

Exclusion Criteria

•patients with limb joint disease and lower limb pain;
•patients with serious heart, liver, kidney diseases could not complete the test;
•patients with visual impairment and hearing impairment;
•patients with a history of mental illness or drug dependence;
•taking antidepressants, levodopa/carbidopa, donepezil hydrochloride and other drugs ;
•patients who received preoperative radiotherapy and chemotherapy;
•Patients with hypothyroidism, Parkinson's disease, stroke and other diseases.